On Demand
Receptor Tyrosine Kinases and Canine Cancer – Palladia and Beyond
Hosted by VetFolio
Dates TBD Online / Virtual
About This Event
This course covers the role of receptor tyrosine kinases in canine cancer, particularly mast cell tumors. It explores targeted RTK inhibitors like toceranib and masitinib, their clinical applications, and the importance of monitoring adverse effects in veterinary oncology treatment.
Sign in to unlock everything networkED.global adds to this event
We enrich every event with details scattered across the web — organized, verified, in one place:
- Earning CE? CE credits, accreditation, and which licenses it counts toward — tracked automatically.
- Speaking? Call-for-proposal deadlines and submission details.
- Exhibiting or sponsoring? Exhibit and sponsorship opportunities.
- Hosting events? Be connected directly to your target audiences.
Plus full agenda, pricing, registration, contacts, and topics covered.
Who This Event Is For
Target Audience
Veterinarians and veterinary oncology specialists treating canine cancer patients, particularly those managing mast cell tumors and other cancers requiring receptor tyrosine kinase inhibitor therapy.